Home › Bronchiolitis Obliterans Syndrome › Florida
Pag-aaral pangklinika para sa Bronchiolitis Obliterans Syndrome sa Florida
14 pag-aaral para sa Bronchiolitis Obliterans Syndrome ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07011810An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Bowden Eye Associates - Southside Location, Jacksonville
- University of Miami, Miller School of Medicine, Bascom Palmer Eye Institute, Miami
Nagre-recruitPhase 3
Edad 10 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07395232Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05996627A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Miami Cancer Institute, Miami
- Orlando Health Cancer Institute Downtown Orlando, Orlando
- Memorial Cancer Institute, Pembroke Pines
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06585774A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Adventhealth Pediatric Cellular Therapy and Blood and Marrow Transplant, Orlando
Nagre-recruitPhase 2
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07124078Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Mayo Clinic Jacksonville, Jacksonville
- AdventHealth Orlando, Orlando
- Moffit Cancer Center, Orlando
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05919511Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Univ of Miami - Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06660355Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- University of Miami, Miami
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06663722A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Miami, Miami
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06615050Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- University of South Florida, Tampa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT06464926A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- AdventHealth Orlando, Orlando
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
- Ambulatory Care Center, Florida International University, Miami
Nagre-recruit
Edad 19 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2025 · NCT07199361Freedom-1 Study for Chronic Knee Pain
- Holy Cross Hospital, Inc, Fort Lauderdale
- Florida Joint Care Institute, Trinity
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2025 · NCT03877653Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.